Quantbot Technologies LP Grows Stock Position in Definitive Healthcare Corp. (NASDAQ:DH)

Quantbot Technologies LP grew its position in shares of Definitive Healthcare Corp. (NASDAQ:DH) by 5,305.5% during the fourth quarter, HoldingsChannel reports. The firm owned 17,730 shares of the company’s stock after buying an additional 17,402 shares during the period. Quantbot Technologies LP’s holdings in Definitive Healthcare were worth $73,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in the company. Principal Financial Group Inc. boosted its holdings in Definitive Healthcare by 9.7% in the fourth quarter. Principal Financial Group Inc. now owns 43,960 shares of the company’s stock valued at $181,000 after purchasing an additional 3,874 shares during the last quarter. Rhumbline Advisers boosted its stake in shares of Definitive Healthcare by 5.2% during the 4th quarter. Rhumbline Advisers now owns 81,316 shares of the company’s stock valued at $334,000 after buying an additional 4,034 shares during the last quarter. Glenmede Trust Co. NA grew its position in shares of Definitive Healthcare by 41.1% during the third quarter. Glenmede Trust Co. NA now owns 18,423 shares of the company’s stock worth $82,000 after buying an additional 5,362 shares in the last quarter. Nisa Investment Advisors LLC grew its position in shares of Definitive Healthcare by 3,652.7% during the fourth quarter. Nisa Investment Advisors LLC now owns 6,980 shares of the company’s stock worth $29,000 after buying an additional 6,794 shares in the last quarter. Finally, Point72 DIFC Ltd increased its stake in shares of Definitive Healthcare by 759.9% in the third quarter. Point72 DIFC Ltd now owns 9,296 shares of the company’s stock worth $42,000 after buying an additional 8,215 shares during the last quarter. 98.67% of the stock is owned by institutional investors and hedge funds.

Definitive Healthcare Trading Down 1.7 %

NASDAQ:DH opened at $2.89 on Tuesday. The firm has a market capitalization of $326.31 million, a P/E ratio of -0.93, a P/E/G ratio of 4.06 and a beta of 1.51. The business has a 50 day simple moving average of $4.07 and a 200 day simple moving average of $4.25. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.49 and a quick ratio of 2.49. Definitive Healthcare Corp. has a 12-month low of $2.55 and a 12-month high of $8.35.

Definitive Healthcare (NASDAQ:DH) last released its quarterly earnings results on Thursday, February 27th. The company reported $0.03 EPS for the quarter, missing the consensus estimate of $0.07 by ($0.04). The firm had revenue of $62.29 million for the quarter, compared to the consensus estimate of $60.60 million. Definitive Healthcare had a positive return on equity of 1.76% and a negative net margin of 142.38%. Equities research analysts predict that Definitive Healthcare Corp. will post 0.16 EPS for the current year.

Analyst Ratings Changes

Several brokerages have weighed in on DH. Needham & Company LLC reissued a “hold” rating on shares of Definitive Healthcare in a report on Thursday, January 16th. Stephens started coverage on Definitive Healthcare in a report on Friday, December 20th. They issued an “equal weight” rating and a $5.00 price objective for the company. Barclays reduced their target price on Definitive Healthcare from $4.00 to $3.00 and set an “underweight” rating on the stock in a report on Monday, March 3rd. Finally, The Goldman Sachs Group lowered their price target on Definitive Healthcare from $4.50 to $3.00 and set a “neutral” rating for the company in a report on Tuesday, March 4th. Two equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Definitive Healthcare presently has an average rating of “Hold” and an average price target of $5.35.

Definitive Healthcare Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.